The frequency of known causative factors of cerebral infarction was studied in 244 cases of first ever stroke due to cerebral infarction proved by computed tomography or at necropsy who were registered in the first two years of a prospective community based study. Risk In this unselected series of patients with first ever stroke due to cerebral infarction most of the strokes were presumed to be due to either atheromatous arterial disease or embolism from the heart, and only 4% (95% confidence interval 2 to 7%) were probably due to non-atheromatous non-embolic causes. This has implications for research into strokes and allocation of public health expenditure.
Introduction
Doctors who care for patients with cerebral infarction are all too aware that most cases are the consequence of atheromatous vascular disease or heart disease; yet there is a long list of rare but potentially treatable conditions that they may have at least to consider in each new patient.' Extensively investigating every patient with stroke, particularly the elderly, is not, however, always appropriate. In deciding on a clinically sensible approach to a typical patient a knowledge of the relative frequency of each of the major causative factors and a sense of proportion about what is important would be helpful.
Studying the relative importance of different potential causative factors in a single sample of patients with stroke may, however, be difficult. A hospital based series of patients is prone to selection bias as those with more severe or unusual types of stroke are more likely to be admitted to hospital.2-4 Community based studies are free of this particular bias but generally have more difficulty in establishing the pathological type of stroke and investigating rare causative factors. There are other methodological problems-for example, the sample should be restricted to patients with their first ever stroke as causative factors are probably different in survivors with recurrent strokes. 56 Attributing cerebral infarction to embolism from the heart poses particular problems: clinical investigators disagree about which cardiac lesions should be considered as definite embolic sources7'9; and deciding whether the stroke was due to embolism is difficult in individual patients with a cardiac lesion. [7] [8] [9] Our aim was to try to avoid at least some of these problems by using data from the Oxfordshire community stroke project. We report our findings in a consecutive series of 244 patients with their first stroke, in whom the stroke was due to cerebral infarction confirmed by computed tomography or at necropsy. This group of patients formed a representative sample of patients with cerebral infarction in the community, both at home and in hospital; all had had a careful clinical assessment, a set of basic laboratory investigations, and careful follow up. We circumvented the problem of embolism from the heart by describing the prevalence of important cardiac lesions in our patients: the presence of such a lesion did not necessarily mean it was considered to be the cause of the cerebral infarct.
Methods
The methods of the study have been described in detail elsewhere.5 10 Briefly, all cases of first ever stroke and transient ischaemic attack in a population of about 104000 "Major" and "minor" potential cardiac sources of emboli-The presence of a cardiac lesion in a patient with a cerebral infarct does not mean that the stroke was necessarily due to embolism from the heart.,-9' Ideally the clinical diagnosis should be supported by evidence from cerebral angiography,7,9 necropsy, or other investigations. In a community based study, however, cerebral angiography can be performed in only a small proportion of patients, and some necropsies were performed several months after the stroke, by which time evidence of embolism had sometimes disappeared. We therefore classified patients by the nature of their cardiac lesion into groups with major and minor potential sources of emboli rather than using unreliable clinical evidence to try to decide whether, in each individual patient, the stroke was due to an embolus from the heart.
Peripheral vascular disease-One or more of the following: clear history of intermittent claudication, peripheral signs (more than two foot pulses absent), or a previous leg amputation (or vascular surgery) for atheromatous arterial disease. Transient ischaemic attacks-Acute loss of focal cerebral or ocular function (symptoms lasting less than 24 hours) presumed to be due to embolic or thrombotic disease after adequate investigation. '9 Diabetes mellitus-One or more of the following: a history of diabetes mellitus, known treatment with oral hypoglycaemic agents or insulin before the stroke, abnormal glucose concentrations measured before the stroke (blood glucose concentration >7-0 mmol/l fasting or >10 mmol/l two hours after a 75 g oral glucose load, or both).
Cervical bruit-A non-transmitted arterial bruit audible in the mid or upper cervical region over the carotid artery or in the supraclavicular region over the subclavian arteries.
Migrainous cerebral infarction-This is defined in detail elsewhere.34 STATISTICAL 
METHOD
The confidence intervals were calculated with the exact method for the confidence interval of a binomial proportion.2" FOLLOW UP Patients were followed up at one month, six months, and one year and yearly thereafter. Any patients with suspected recurrent stroke were re-examined by the study neurologist.
Results
Between 1 November 1981 and 31 October 1983, 323 patients with first ever stroke were registered, of whom 244 had cerebral infarction, 28 primary intracerebral haemorrhage, and 19 subarachnoid haemorrhage verified by computed tomography or at necropsy (or by lumbar puncture in patients with subarachnoid haemorrhage). Thirty two patients who did not undergo either computed tomography or necropsy were classified as "pathological type unknown." This report is confined to the 244 patients with cerebral infarction. The cardiologist assessed 105 of these patients, of whom 99 had echocardiography.
ACCURACY OF DIAGNOSIS OF CARDIAC LESIONS
On the assumption that the cardiologist's diagnosis was correct, the neurologists' diagnosis of an abnormal heart had a sensitivity of 92%, a specificity of 91%, a positive predictive value of 93%, and a negative predictive value of 91%; the likelihood ratio of a cardiac abnormality being present if the neurologist diagnosed an abnormal heart was 10 2."l The observed agreement between neurologists and the cardiologist in the diagnosis of an abnormal heart was 92%. The kappa statistic, a measure of the degree of agreement over and above the effects of chance, was 0-84 (this result would be regarded as more than satisfactory for a clinical diagnosis2).
HYPERTENSION
Data on blood pressure were available for 220 patients who had had at least one measurement before the stroke; in 190 the general practitioner had measured the blood pressure within five years of the stroke. OTHER RISK FACTORS Table II shows the prevalence of risk factors for cerebral infarction. The prevalence of ischaemic heart disease and peripheral vascular disease was high. 4Ten of these patients were aged over 80.
active neurosyphilis in the patients. Since this report was first prepared one case of stroke due to neurosyphilis has been registered. The observed prevalence of cerebral infarction due to this condition was thus 1/515 (0 2%) (95% confidence interval 0 to 0-6%).
We did not identify any patients with strokes related to pregnancy, polycythaemia rubra vera, Fabry's disease, or homocystinuria. This might be accounted for by chance: an observed frequency of0/244 cases has an upper 95% confidence limit of four cases, or 1-5%.
Overall, non-atheromatous, non-embolic conditions seemed to be the only predisposing factors in 10 (4%), (95% confidence interval 2 to 7%) of patients with first ever strokes due to cerebral infarction (table VI) . BMJ VOLUME 298 many patients in this study had had their blood pressure recorded before their stroke suggests that the United Kingdom's system of primary healh care is well suited to achieving high levels of detection and treatment of hypertension.
Although a fifth of the patients in our series had a cardiac lesion that might be considered a major potential source of emboli to the brain, the cardiac lesion was the sole possible predisposing factor in only seven cases (3%). Twelve patients had had a myocardial infarction less than six weeks before the stroke, but in none of these patients was there clinical, echocardiographic, or necropsy evidence that the stroke was definitely due to embolism from the heart. If these patients are included a cardiac lesion was the sole predisposing cause in 19 (8%), though if patients with risk factors are included the proportion rises to 20%. The difficulties of deciding in individual patients whether a cardiac lesion was definitely the cause of cerebral infarction are well known,89 18 and our findings emphasise that the presence of a cardiac lesion does not necessarily imply that it was the cause of the stroke. Notably, rheumatic heart disease was uncommon in our patients.
The relevance of minor cardiac lesions (such as aortic sclerosis, mitral annulus calcification, and mitral leaflet prolapse, especially in elderly patients with atheromatous arterial disease or risk factors) in causing cerebral infarction is even less clear. 7 The results of a case-control study being undertaken by one of us (IRS) should elucidate further the role of some of these cardiac lesions in cerebral infarction.
The cases in which arteritis was a potential predisposing cause of cerebral infarction were of interest. Only two of the patients in whom the cerebral infarction was definitely or probably caused by arteritis were free of vascular risk factors. In the patient with granulomatous angiitis the diagnosis, though suspected, was not confirmed in life and was proved only at necropsy. None the less, the patient was regarded as possibly having arteritis and treated with oral steroids. One patient (case 2) with giant cell arteritis proved by biopsy abruptly stopped taking steroids shortly after starting them, and this almost certainly led to her stroke. Cerebral arteritis was probably the cause in two cases (3 and 4), but confirmatory tests were not done, though the dramatic response to increased oral steroids in case 4 supported the diagnosis. All four cases show the importance of considering arteritis in a patient with stroke with a raised erythrocyte sedimentation rate, particularly if there is a history of polymyalgia rheumatica. Biopsy of the temporal arteries in every patient with stroke with a raised erythrocyte sedimentation rate (greater than 40 mm in the first hour) probably does not yield sufficient positive results to be justifiable33: none the less, we possibly underestimated the proportion of strokes due to arteritis.
Only one patient with cerebral infarction had previously used oral contraceptives, and she had other risk factors as well. This finding emphasises that, though use of oral contraceptives may increase the relative risk of stroke, the proportion of all strokes attributable to the effects of oral contraceptives is small because of the low absolute risk of stroke in the age group using them.
Notably, despite the fact that 96% of patients in our series had serological tests for syphilis, there was only one case of cerebral infarction definitely attributable to meningovascular syphilis, though this could reflect our small sample size or the nature of the Oxfordshire population, which has a low prevalence of syphilis.
The general practitioner or general physician managing patients with stroke should always consider the rare and unusual causes of cerebral infarction as they may be treatable,' 1924-2734 but an overzealous search for rare conditions may lead to inappropriate, expensive, and sometimes risky investigations with little hope of finding treatable disease. In our series non-atheromatous non-embolic conditions predisposing to cerebral infarction were present in only 4 These preliminary results are encouraging, but as wide fluctuations in serum aminotransferase activities occur in chronic non-A non-B hepatitis,7 controlled studies are essential. This study aimed at assessing the effect of low dose interferon alfa on aminotransferase activities in a randomised controlled study of patients with established chronic non-A non-B hepatitis.
Patients and methods
The study was an open randomised controlled parallel group study of interferon versus no treatment in patients with chronic non-A non-B hepatitis. Fourteen patients with the disease recruited from a hepatology clinic were randomised (sealed envelopes) on entry to the study. The table gives their details. All except two patients had a history of parenteral exposure to blood or blood products and the subsequent development of chronic hepatitis with persistently raised serum aminotransferase activities and liver biopsy appearances compatible with chronic non-A non-B hepatitis. All were negative for hepatitis B surface antigen, but one treated patient (case 3) had IgG core antibodies indicating previous exposure to hepatitis B. Other causes of chronic hepatitis were excluded by finding normal serum oa antitrypsin, iron, transferrin, caeruloplasmin, and copper concentrations. No patient had antinuclear or mitochondrial antibodies, but several patients had low titres (< 1/40) of smooth muscle antibody. Alcohol and drug induced liver disease were also excluded after careful questioning. All patients were negative for antibody to human immunodeficiency virus (HIV) at entry to the study, but one treated patient (case 5) seroconverted to HIV shortly after starting interferon. Patients gave informed consent and the study was approved by the local ethical committees.
Treatment was with interferon alfa (Wellferon). The interferon was given by intramuscular or deep subcutaneous injection and the patients taught to self inject. The 
